In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis
- PMID: 20154226
- PMCID: PMC2872538
- DOI: 10.1189/jlb.1109763
In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis
Abstract
Inflammation is the body's initial response to infection, which is harmful when excessive, as exemplified in sepsis inflammatory syndromes. Ectodomain shedding by the membrane metalloprotease ADAM17 is an emerging regulator of inflammation, as it directs the activity of various inflammatory modulators. At this time, however, little is known about the in vivo function of ADAM17. Here, we show that ADAM17-deficient leukocytes afforded mice a survival benefit following Escherichia coli-mediated peritoneal sepsis, which was associated with a reduction in systemic proinflammatory cytokine levels and bacterial burden. A more rapid yet transitory neutrophil infiltration into the peritoneal cavity of conditional ADAM17 knockout mice was observed when compared with control mice, suggesting a mechanism for their enhanced clearance of bacteria. Preventing the shedding of L-selectin augments neutrophil recruitment, and we show that L-selectin shedding by peritoneal neutrophils in conditional ADAM17 knockout mice was impaired. Moreover, their peritoneal TNF-alpha levels were markedly lower than control mice following E. coli challenge. These events indicate key molecular processes involved in the altered time course of neutrophil recruitment in conditional ADAM17 knockout mice. Overall, our study provides novel in vivo evidence of the instrumental role of ADAM17 in modulating inflammation and host resistance during Gram-negative bacterial infection.
Figures



Similar articles
-
IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance.J Immunol. 2001 May 15;166(10):6323-31. doi: 10.4049/jimmunol.166.10.6323. J Immunol. 2001. PMID: 11342656
-
ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment.J Leukoc Biol. 2012 Sep;92(3):667-72. doi: 10.1189/jlb.0312112. Epub 2012 May 23. J Leukoc Biol. 2012. PMID: 22623356 Free PMC article.
-
ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.J Immunol. 2010 Apr 15;184(8):4447-54. doi: 10.4049/jimmunol.0902925. Epub 2010 Mar 10. J Immunol. 2010. PMID: 20220092 Free PMC article.
-
Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis.Front Cell Infect Microbiol. 2017 Apr 25;7:138. doi: 10.3389/fcimb.2017.00138. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28487846 Free PMC article. Review.
-
[The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity].Med Sci (Paris). 2009 Jan;25(1):45-50. doi: 10.1051/medsci/200925145. Med Sci (Paris). 2009. PMID: 19154693 Review. French.
Cited by
-
Hydrogen sulfide reduces neutrophil recruitment in hind-limb ischemia-reperfusion injury in an L-selectin and ADAM-17-dependent manner.Plast Reconstr Surg. 2013 Mar;131(3):487-497. doi: 10.1097/PRS.0b013e31827c6e9c. Plast Reconstr Surg. 2013. PMID: 23446563 Free PMC article.
-
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis.Int J Mol Sci. 2020 Sep 12;21(18):6688. doi: 10.3390/ijms21186688. Int J Mol Sci. 2020. PMID: 32932701 Free PMC article.
-
A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems.Front Physiol. 2016 Oct 18;7:469. doi: 10.3389/fphys.2016.00469. eCollection 2016. Front Physiol. 2016. PMID: 27803674 Free PMC article. Review.
-
Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation.J Biol Chem. 2011 Nov 11;286(45):38980-8. doi: 10.1074/jbc.M111.277087. Epub 2011 Sep 23. J Biol Chem. 2011. PMID: 21949123 Free PMC article.
-
Contribution of ADAM17 and related ADAMs in cardiovascular diseases.Cell Mol Life Sci. 2021 May;78(9):4161-4187. doi: 10.1007/s00018-021-03779-w. Epub 2021 Feb 11. Cell Mol Life Sci. 2021. PMID: 33575814 Free PMC article. Review.
References
-
- Reiss K, Saftig P. The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol. 2009;20:126–137. - PubMed
-
- Garton K J, Gough P J, Raines E W. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol. 2006;79:1105–1116. - PubMed
-
- Black R A, Rauch C T, Kozlosky C J, Peschon J J, Slack J L, Wolfson M F, Castner B J, Stocking K L, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley K A, Gerhart M, Davis R, Fitzner J N, Johnson R S, Paxton R J, March C J, Cerretti D P. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature. 1997;385:729–733. - PubMed
-
- Moss M L, Jin S L, Milla M E, Bickett D M, Burkhart W, Carter H L, Chen W J, Clay W C, Didsbury J R, Hassler D, Hoffman C R, Kost T A, Lambert M H, Leesnitzer M A, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton L K, Schoenen F, Seaton T, Su J L, Becherer J D. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature. 1997;385:733–736. - PubMed
-
- Walcheck B, Herrera A H, Hill C S, Mattila P E, Whitney A R, Deleo F R. ADAM17 activity during human neutrophil activation and apoptosis. Eur J Immunol. 2006;36:968–976. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous